|
Document And Entity Information (USD $)
|
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2012
|
Mar. 08, 2013
|
Jun. 30, 2011
|
|
| Document Information [Line Items] | |||
| Entity Registrant Name | Tonix Pharmaceuticals Holding Corp. | ||
| Entity Central Index Key | 0001430306 | ||
| Current Fiscal Year End Date | --12-31 | ||
| Entity Filer Category | Smaller Reporting Company | ||
| Trading Symbol | TNXP | ||
| Entity Common Stock, Shares Outstanding | 43,182,599 | ||
| Document Type | 10-K | ||
| Amendment Flag | true | ||
| Document Period End Date | Dec. 31, 2012 | ||
| Document Fiscal Period Focus | FY | ||
| Document Fiscal Year Focus | 2012 | ||
| Entity Well-known Seasoned Issuer | No | ||
| Entity Voluntary Filers | No | ||
| Entity Current Reporting Status | Yes | ||
| Entity Public Float | $ 0 | ||
| Amendment Description | Tonix Pharmaceuticals Holding Corp. (the “Company”) is filing this Amendment No. 1 on Form 10-K/A (the “Amended Filing”) to the Company’s Annual Report on Form 10-K for the year ended December 31, 2012 (the “Original Filing”) filed with the Securities and Exchange Commission (“SEC”) on March 11, 2013, in order to update the report from the Company’s independent registered public accounting firm, the consolidated financial statements and the notes thereto (collectively, the “Financials”) as was updated for the Company’s registration statement on Form S-1 (SEC file 333-188547) (the “Registration Statement”). Subsequent to the Original Filing and prior to the Registration Statement, the Company effectuated a 1-for-20 reverse stock split of its outstanding common stock. As a result, all per share amounts and number of shares (other than authorized shares) in the Financials were retroactively restated in the Registration Statement to reflect the reverse stock split resulting in the transfer of $41,024 from common stock to additional paid in capital at December 31, 2012. As the Company intends to incorporate by reference the Financials in a registration statement on Form S-3, the Company is making this Amended Filing to facilitate the incorporation by reference of the Financials. For the convenience of the reader, this Amended Filing sets forth the Original Filing in its entirety. However, this Amended Filing only amends the report from the Company’s independent registered public accounting firm, the consolidated financial statements and the notes thereto, as disclosed above. No other information in the Original Filing is amended hereby. In addition, pursuant to the rules of the SEC, Item 15 of Part IV to the Original Filing has been amended to contain currently dated certifications from our Principal Executive Officer and Principal Financial Officer, as required by Sections 302 and 906 of the Sarbanes-Oxley Act of 2002. The certifications of our Principal Executive Officer and Principal Financial Officer are attached to this Amended Filing as Exhibits 31.01, 31.02 and 32.01. |